Form D Explorer

Form C-AR — Deverra Therapeutics, Inc.

0001665160-24-000561 · filed 2024-04-26

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: Deverra Therapeutics, Inc.
CIK: 1822782
Entity: Corporation
Jurisdiction: DE
Address: 1600 Fairview Ave E STE 300
Seattle, WA 98102
Phone: —

Most recent fiscal year financials

Total assets

$7,153,621

Cash

—

Short-term debt

$7,222,643

Long-term debt

—

Revenues

$1,677,259

COGS

$1,677,259

Taxes paid

—

Net income

$1,672,096

View original on SEC EDGAR.